Published in EMBO J on October 01, 1987
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proc Natl Acad Sci U S A (1992) 5.19
HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J (1989) 4.73
Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc Natl Acad Sci U S A (1989) 4.15
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother (1992) 2.97
Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J (1991) 2.97
Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J Virol (1992) 2.89
Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc Natl Acad Sci U S A (1994) 2.56
HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity. EMBO J (1990) 2.54
Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain. Proc Natl Acad Sci U S A (1989) 2.06
Two novel heat shock genes encoding proteins produced in response to heterologous protein expression in Escherichia coli. J Bacteriol (1992) 1.98
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci U S A (1991) 1.79
Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res (1989) 1.75
Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA. Nucleic Acids Res (1989) 1.61
Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1992) 1.48
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1994) 1.40
Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases. Antimicrob Agents Chemother (1989) 1.23
Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function. J Virol (1988) 1.20
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes. Proc Natl Acad Sci U S A (1998) 1.14
Authentic reverse transcriptase is coded by jockey, a mobile Drosophila element related to mammalian LINEs. EMBO J (1991) 1.12
Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity. J Virol (1988) 1.08
Effects of site-directed mutations on processing and activities of penicillin G acylase from Escherichia coli ATCC 11105. J Bacteriol (1992) 1.07
Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1990) 1.03
Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma. Antimicrob Agents Chemother (1989) 1.03
In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol (1991) 0.99
Human immunodeficiency virus-1 reverse transcriptase heterodimer stability. Protein Sci (1994) 0.96
Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA. Nucleic Acids Res (1995) 0.95
Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (1998) 0.91
Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli. J Virol (1990) 0.89
Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant. J Virol (1998) 0.86
Detection of an RNase H activity associated with hepadnaviruses. J Virol (1995) 0.83
Domain structure of the human immunodeficiency virus reverse transcriptase. EMBO J (1992) 0.80
Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci U S A (1991) 0.77
Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol (1993) 0.75
Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene (1983) 44.52
Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (1985) 30.62
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res (1982) 13.52
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science (1985) 10.97
The tac promoter: a functional hybrid derived from the trp and lac promoters. Proc Natl Acad Sci U S A (1983) 9.95
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc Natl Acad Sci U S A (1986) 6.94
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science (1985) 6.48
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol (1986) 5.05
Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science (1987) 3.46
DNA-binding proteins induced by herpes simplex virus type 2 in HEp-2 cells. J Virol (1976) 3.29
Strategies for antiviral therapy in AIDS. Nature (1987) 2.95
Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli. J Virol (1986) 1.84
In vitro site-directed mutagenesis with synthetic DNA oligonucleotides yields unexpected deletions and insertions at high frequency. Nucleic Acids Res (1983) 1.59
PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob Agents Chemother (1986) 1.30
Studies on the herpes simplex virus alkaline nuclease: detection of type-common and type-specific epitopes on the enzyme. J Gen Virol (1985) 1.14
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science (1989) 14.63
Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature (1987) 4.45
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis (1992) 4.21
The Worm Community System, release 2.0 (WCSr2). Methods Cell Biol (1995) 4.18
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr (1998) 3.96
Related functional domains in virus DNA polymerases. EMBO J (1987) 3.35
The replication of bacteriophage phi X174 DNA in vitro. Temperature effects on repair synthesis and displacement synthesis. Biochim Biophys Acta (1971) 3.07
High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat Struct Biol (1995) 3.04
Outpatient cataract surgery 1982-1986. Eye (Lond) (1987) 2.80
Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr (1994) 2.79
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. Lancet (1990) 2.50
The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol (1989) 2.40
Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother (1980) 2.17
Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. J Gen Virol (1980) 2.07
Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat Med (1998) 2.07
Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature (1981) 2.03
Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol (1980) 2.01
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99
Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89
Herpes simplex virus non-structural proteins. III. Function of the major DNA-binding protein. J Gen Virol (1983) 1.79
Improved conversion of methanol to single-cell protein by Methylophilus methylotrophus. Nature (1980) 1.69
Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell (1978) 1.69
Extracting noun phrases for all of MEDLINE. Proc AMIA Symp (1999) 1.60
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
Cervical spine clearance in Australian intensive care units. Crit Care Resusc (2003) 1.40
Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex. J Biol Chem (1996) 1.39
Population estimates of household firearm storage practices and firearm carrying in Oregon. JAMA (1996) 1.38
Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol (1989) 1.33
Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. J Biol Chem (1983) 1.31
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Virus drug-resistance: mechanisms and consequences. Antiviral Res (1984) 1.29
Preliminary report on the northern Australian melioidosis environmental surveillance project. Epidemiol Infect (2004) 1.25
Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J Gen Virol (1987) 1.23
Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. J Gen Virol (1983) 1.22
Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function. J Virol (1988) 1.20
The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs. J Infect Dis (1981) 1.20
Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev (1999) 1.19
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res (2010) 1.18
Initial experience with the Cosgrove-Edwards Annuloplasty System. Ann Thorac Surg (1995) 1.15
Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology (1985) 1.13
Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol (1990) 1.12
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment. Drug Alcohol Depend (2000) 1.09
Tuberculosis among the homeless, United States, 1994-2010. Int J Tuberc Lung Dis (2013) 1.01
Cooperative effects between two acyclovir resistance loci in herpes simplex virus. J Virol (1984) 1.01
Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Antimicrob Agents Chemother (1986) 1.01
Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1. J Gen Virol (1986) 1.00
A Community's Awareness and Perceptions of Genomic Medicine. Public Health Genomics (2009) 1.00
The detection of virus DNA sequences in a herpes type 2 transformed hamster cell line (333-8-9). Int J Cancer (1976) 0.99
Tissue distribution of the human soluble guanylate cyclases. Biochem Biophys Res Commun (1999) 0.99
Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther (1990) 0.99
RNA-RNA hybridisation using 125I-labelled RNA from tobacco necrosis virus and its satellite. Nature (1974) 0.98
Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur J Clin Pharmacol (1996) 0.98
Semi-automated segmentation to assess the lateral meniscus in normal and osteoarthritic knees. Osteoarthritis Cartilage (2009) 0.98
Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant. J Virol (1982) 0.97
Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus. J Med Virol (1993) 0.97
Tamoxifen-induced hypercalcemia in breast cancer. Cancer (1981) 0.97
Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax (2008) 0.96
Heat inactivation of vaccinia virus particle-associated functions: properties of heated particles in vivo and in vitro. J Virol (1978) 0.94
Mutations associated with zidovudine resistance in HIV-1 among recent seroconvertors. AIDS (1997) 0.93
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol (1997) 0.93
Walking the journey of womanhood: Yakama Indian women and Papanicolaou (Pap) test screening. Public Health Nurs (1996) 0.92
Sensitivity of viruses to phosphorylated 9-(2-hydroxyethoxymethyl)guanine revealed in TK-transformed cells. J Gen Virol (1980) 0.92
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine. Pharmacogenetics (1999) 0.91
Commensal ocular bacteria degrade mucins. Br J Ophthalmol (2002) 0.90
Body composition, dietary carbohydrates and fatty acids determine post-fertilisation development of bovine oocytes in vitro. Reproduction (2006) 0.89
A ground-layer adaptive optics system with multiple laser guide stars. Nature (2010) 0.89
Fulminant pneumonia caused by concomitant infection with influenza B virus and Staphylococcus aureus. J Pediatr (1985) 0.89
Uptake of carbon monoxide from the urinary bladder of the dog. Am J Physiol (1968) 0.88
Epidemic sporotgrichosis. JAMA (1971) 0.88
Latency and acquired resistance--problems in chemotherapy of herpes infections. Pharmacol Ther (1983) 0.88
Cortical bone structure of the pig mandible. Arch Oral Biol (1973) 0.87
Extraction of RNA from mammalian tissue culture cells. Anal Biochem (1974) 0.86
Cell-cell contact and membrane spreading in an ultrasound trap. Colloids Surf B Biointerfaces (2004) 0.86
Helicobacter pylori and metronidazole resistance. Lancet (1990) 0.85
Letter: 3'-Terminal oligonucleotide fragments of tobacco rattle virus ribonucleic acids. J Mol Biol (1973) 0.85
Viruses and renal carcinoma of Rana pipiens. XIV. Temperature-sensitive mutants of frog virus 3 with defective encapsidation. Virology (1973) 0.85
Macromolecular synthesis in cells infected with frog virus 3. III. Virus-specific protein synthesis by temperature-sensitive mutants. Virology (1975) 0.84
The structure of the DNA of bacteriophage phiX174. VI. Pyrimidine sequences in the complementary strand of the replicative form. J Mol Biol (1970) 0.84
Preen gland function in layer fowls: factors affecting preen oil fatty acid composition. Br Poult Sci (2004) 0.83
Photoreceptor membrane breakdown in the spider Dinopis: the fate of rhabdomere products. Cell Tissue Res (1978) 0.83
Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response. Public Health Rep (1995) 0.82
Necrotizing neurosarcoid: three cases with varying presentations. Clin Neuropathol (2007) 0.82
Alignment of the medial tibial plateau affects the rate of joint space narrowing in the osteoarthritic knee. Osteoarthritis Cartilage (2010) 0.82
Hereditary angioedema and pregnancy. J Matern Fetal Neonatal Med (2007) 0.82
Replication of varicella zoster virus in primary human keratinocytes. J Med Virol (1992) 0.82
Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine. Ther Drug Monit (1998) 0.82
13C-urea breath test for Helicobacter pylori infection. Gut (1991) 0.81
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. Ther Drug Monit (1996) 0.81
Evaluation of kinetic constants for mixed inhibitors of cholinesterase. Biochem Pharmacol (1967) 0.81
Adenovirus late sequences linked to herpes simplex virus thymidine kinase may be introduced into eukaryotic cells and transcribed. Nucleic Acids Res (1981) 0.81
Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? Aliment Pharmacol Ther (1992) 0.81
Analysis of the role of the cysteine 171 residue in the activity of herpes simplex virus type 1 thymidine kinase by oligonucleotide-directed mutagenesis. J Gen Virol (1987) 0.80
Isolation and characterization of acyclovir-resistant strains of herpes simplex virus. Am J Med (1982) 0.80
Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl (1996) 0.80
Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV. J Gen Virol (1995) 0.80
Photoreceptor membrane breakdown in the spider Dinopis: GERL differentiation in the receptors. Cell Tissue Res (1978) 0.79
Membrane internalization processes in different stages of Schistosoma mansoni as shown by a styryl dye (Frei Mao 1-43). Parasitology (1998) 0.79
Interactive medical data on demand: a high-performance imaged-based approach across heterogeneous environments. Stud Health Technol Inform (2000) 0.77